Harmony Biosciences Holdings Profit Margin

Harmony Biosciences Holdings's profit margin stands at 18.88% as of June 2026. That compares with 23.42% in the prior-year period — down 19.4% year over year. That is above the Healthcare sector average of 14.34%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Harmony Biosciences Holdings reported 18.88% in profit margin versus 23.42% a year earlier — a 19.4% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Harmony Biosciences Holdings sits higher the Healthcare benchmark (14.34%) with a profit margin of 18.88%. That is roughly 31.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 18.88% for Harmony Biosciences Holdings means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Harmony Biosciences Holdings's profit margin evolved across reporting periods, while the comparison chart places HRMY next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.